Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 5,020.00
+165.00 (3.40%)
At close: May 14, 2026
-8.34% (1Y)
| Market Cap | 55.42B -10.7% |
| Revenue (ttm) | 22.18B +2.6% |
| Net Income | 2.97B -22.3% |
| EPS | 261.00 -28.9% |
| Shares Out | 11.04M |
| PE Ratio | 19.23 |
| Forward PE | n/a |
| Dividend | 185.00 (3.81%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 42,946 |
| Average Volume | 34,826 |
| Open | 4,885.00 |
| Previous Close | 4,855.00 |
| Day's Range | 4,875.00 - 5,040.00 |
| 52-Week Range | 4,560.00 - 7,690.00 |
| Beta | n/a |
| RSI | 41.35 |
| Earnings Date | May 21, 2026 |